A detailed history of William Blair Investment Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, William Blair Investment Management, LLC holds 1,674,799 shares of BPMC stock, worth $152 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,674,799
Previous 1,593,916 5.07%
Holding current value
$152 Million
Previous $172 Million 9.86%
% of portfolio
0.4%
Previous 0.47%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$84.1 - $120.5 $6.8 Million - $9.75 Million
80,883 Added 5.07%
1,674,799 $155 Million
Q2 2024

Aug 08, 2024

SELL
$85.18 - $108.78 $9.72 Million - $12.4 Million
-114,132 Reduced 6.68%
1,593,916 $172 Million
Q1 2024

May 08, 2024

SELL
$73.17 - $99.79 $1.45 Million - $1.98 Million
-19,797 Reduced 1.15%
1,708,048 $162 Million
Q4 2023

Feb 09, 2024

BUY
$43.96 - $92.84 $11.9 Million - $25.2 Million
271,216 Added 18.62%
1,727,845 $159 Million
Q3 2023

Nov 09, 2023

SELL
$46.9 - $66.0 $837,680 - $1.18 Million
-17,861 Reduced 1.21%
1,456,629 $73.2 Million
Q2 2023

Aug 10, 2023

BUY
$42.2 - $66.37 $16.5 Million - $26 Million
392,041 Added 36.22%
1,474,490 $93.2 Million
Q1 2023

May 12, 2023

BUY
$37.97 - $50.0 $2.2 Million - $2.89 Million
57,835 Added 5.64%
1,082,449 $48.7 Million
Q4 2022

Feb 09, 2023

SELL
$41.06 - $66.48 $2.04 Million - $3.3 Million
-49,670 Reduced 4.62%
1,024,614 $44.9 Million
Q3 2022

Nov 09, 2022

BUY
$49.93 - $77.7 $457,159 - $711,421
9,156 Added 0.86%
1,074,284 $70.8 Million
Q2 2022

Aug 10, 2022

SELL
$45.23 - $70.15 $922,149 - $1.43 Million
-20,388 Reduced 1.88%
1,065,128 $53.8 Million
Q1 2022

May 11, 2022

SELL
$54.1 - $110.08 $35.8 Million - $72.9 Million
-662,205 Reduced 37.89%
1,085,516 $69.3 Million
Q4 2021

Feb 14, 2022

BUY
$94.25 - $115.99 $2.88 Million - $3.54 Million
30,557 Added 1.78%
1,747,721 $187 Million
Q3 2021

Nov 10, 2021

BUY
$80.98 - $109.47 $55.2 Million - $74.6 Million
681,246 Added 65.76%
1,717,164 $177 Million
Q2 2021

Aug 12, 2021

SELL
$82.78 - $101.0 $1.93 Million - $2.36 Million
-23,353 Reduced 2.2%
1,035,918 $91.1 Million
Q1 2021

May 13, 2021

BUY
$90.71 - $108.28 $6.94 Million - $8.28 Million
76,457 Added 7.78%
1,059,271 $103 Million
Q4 2020

Feb 09, 2021

BUY
$92.08 - $124.48 $90.5 Million - $122 Million
982,814 New
982,814 $110 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.